Wag! Group (PET) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Q4 2024 showed a rebound from Q3, with platform participants, revenue, and adjusted EBITDA all increasing over 17% sequentially.
Full year 2024 revenue was $70.5 million, down 16% year-over-year but within guidance.
Net loss for Q4 2024 was $4.8 million versus $3.5 million in Q4 2023; full-year net loss was $17.6 million compared to $13.3 million in 2023.
The company is undergoing a board-led strategic review to enhance shareholder value, including potential sale, merger, or partnerships, with no set timeline for completion.
Three new major distribution partners were signed in Q4, expected to drive growth in the wellness segment starting Q1 2025.
Financial highlights
Q4 revenue reached $15.4 million, with an adjusted EBITDA loss of $963,000.
Full year adjusted EBITDA loss was $1.1 million, compared to a $0.7 million profit in 2023.
Full year segment revenues: Services $21.6M, Wellness $42.7M, Pet Food & Treats $6.2M.
Ended 2024 with $5.6 million in cash and equivalents, down from $18.3 million in 2023.
Net cash used in operating activities for 2024 was $7.0 million, compared to $6.5 million in 2023.
Outlook and guidance
2025 revenue guidance is $84–$88 million, with adjusted EBITDA expected between $2–$4 million.
Revenue growth in 2025 is expected to be driven primarily by the wellness segment and new partnerships.
Sequential revenue growth anticipated throughout 2025 as new partners scale.
Latest events from Wag! Group
- Record adjusted EBITDA and improved margins achieved, but liquidity and debt risks persist.PET
Q2 20242 Feb 2026 - Q3 revenue fell 39% with deepening losses, but Wellness rebounded and debt reduction continues.PET
Q3 202414 Jan 2026 - Q1 2025 revenue fell 34.7%, net loss widened, and liquidity risks persist despite new partnerships.PET
Q1 202527 Nov 2025 - Chapter 11 filing, revenue drop, delisting, and asset sale mark a critical restructuring phase.PET
Q2 20257 Aug 2025